Nifty Pharma Index Rises 0.3% as Zydus Life, Dr Reddys Lab, Ajanta Pharma Lead Gainers
- July 8, 2026
- Posted by: Kunal Singla
- Category: News
Nifty Pharma index up 0.3% on 8 Jul 2026. Zydus Life up 1.14% at Rs 1,166.20, Dr Reddys up 0.9% at Rs 1,366.80. Ajanta Pharma, Torrent Pharma, Cipla, Sun Pharma also gain.
The Nifty Pharma index rose 0.3 percent in intraday trade on Wednesday, 8 July 2026, standing out as one of the few sectors in the green even as the broader market traded weak on global cues. Zydus Life, Dr Reddy’s Lab and Ajanta Pharma were among the top contributors to the index gain.
Zydus Life led the pharma pack with a 1.14 percent gain to Rs 1,166.20, followed by Dr Reddy’s Labs which rose 0.9 percent to Rs 1,366.80, as the Nifty Pharma index attracted buying interest amid the broader selloff.
Click Here – Get Free Investment Predictions
Nifty Pharma Top Stock Gainers Today
| Company | CMP | Chg(%) | Volume |
|---|---|---|---|
| Zydus Life | Rs 1,166.20 | +1.14 percent | 722.49k |
| Dr Reddys Labs | Rs 1,366.80 | +0.90 percent | 448.14k |
| Ajanta Pharma | Rs 3,341.60 | +0.82 percent | 29.23k |
| Torrent Pharma | Rs 4,896.30 | +0.82 percent | 53.34k |
| JB Chemicals | Rs 2,437.00 | +0.62 percent | 91.40k |
| Cipla | Rs 1,459.30 | +0.52 percent | 212.14k |
| Lupin | Rs 2,502.90 | +0.51 percent | 194.88k |
| Aurobindo Pharm | Rs 1,590.60 | +0.47 percent | 182.06k |
| Sun Pharma | Rs 1,910.90 | +0.39 percent | 571.33k |
| Alkem Lab | Rs 5,686.00 | +0.33 percent | 17.12k |
| Divis Labs | Rs 6,788.50 | +0.25 percent | 38.76k |
| Wockhardt | Rs 1,860.00 | +0.14 percent | 120.25k |
Get Pharma Sector Guidance from a SEBI Registered Investment Advisor at Univest
Why the Nifty Pharma Index Is Outperforming Today
Pharma stocks are traditionally viewed as a defensive sector during periods of macro uncertainty, since demand for medicines is relatively inelastic regardless of oil prices, currency moves or geopolitical tensions. With crude oil rallying on renewed US Iran conflict and rate sensitive sectors such as banking and aviation under pressure, investors appear to have rotated some capital into pharma names.
The breadth of gains across the Nifty Pharma index, spanning large caps like Sun Pharma and Cipla to mid sized names like JB Chemicals and Ajanta Pharma, suggests broad based buying rather than a single stock specific trigger.
What Should Investors Watch in the Nifty Pharma Index
Investors tracking the Nifty Pharma index should watch Q1 FY27 earnings commentary on US generics pricing, domestic formulation growth and R&D pipeline updates. Currency movements also matter given the sector’s significant export revenue exposure to the US market.
Download the Univest iOS App or Univest Android App to track pharma stocks live and get daily research updates.
Conclusion
The Nifty Pharma index rose 0.3 percent on 8 July 2026, led by Zydus Life, Dr Reddy’s Lab and Ajanta Pharma, as defensive pharma names outperformed a weak broader market hurt by rising crude oil prices. Investors should track Q1 FY27 earnings and export trends, and consult a SEBI registered advisor before investing in pharma stocks.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions FAQs
Why did the Nifty Pharma index rise today?
Ans. The Nifty Pharma index rose 0.3 percent on 8 July 2026 as investors rotated into defensive pharma stocks while the broader market fell on rising crude oil prices and global tensions.
How many stocks make up the Nifty Pharma index?
Ans. The Nifty Pharma index tracks a basket of major listed pharmaceutical companies, including Zydus Life, Dr Reddys Labs, Sun Pharma, Cipla, Lupin and Divis Labs among its key constituents.
Which pharma stock gained the most today?
Ans. Zydus Life was the top gainer on the Nifty Pharma index, rising 1.14 percent to Rs 1,166.20 on 8 July 2026.
What is the Dr Reddy’s Labs share price today?
Ans. Dr Reddy’s Labs share price was trading at Rs 1,366.80 on 8 July 2026, up 0.9 percent, making it one of the top contributors to the Nifty Pharma index gain.
Why is pharma considered a defensive sector?
Ans. Pharma is considered defensive because demand for medicines remains relatively stable regardless of macroeconomic or geopolitical conditions, unlike oil sensitive or rate sensitive sectors.
Which other pharma stocks gained today?
Ans. Ajanta Pharma, Torrent Pharma, JB Chemicals, Cipla, Lupin, Aurobindo Pharma, Sun Pharma, Alkem Lab, Divis Labs and Wockhardt all posted gains between 0.14 and 0.82 percent on 8 July 2026.
Should investors buy pharma stocks after today’s gains?
Ans. A single day of outperformance is not a standalone buy signal. Investors should review Q1 FY27 earnings, US generics pricing trends and valuations, and consult a SEBI registered investment advisor before investing.
